$NBSE NeuBase Therapeutics, Inc. Insider Trading Week 44/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NeuBase Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NeuBase Therapeutics, Inc. in week 44/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.01 | 100 | 301 | 77,923 | 77.8 K to 77.9 K (+0.13 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.03 | 1,400 | 4,242 | 77,823 | 76.4 K to 77.8 K (+1.83 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.03 | 200 | 606 | 76,423 | 76.2 K to 76.4 K (+0.26 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.02 | 200 | 604 | 76,223 | 76 K to 76.2 K (+0.26 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.02 | 200 | 604 | 76,023 | 75.8 K to 76 K (+0.26 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.01 | 1,300 | 3,913 | 75,823 | 74.5 K to 75.8 K (+1.74 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.00 | 2,600 | 7,800 | 74,523 | 71.9 K to 74.5 K (+3.61 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.00 | 300 | 900 | 71,923 | 71.6 K to 71.9 K (+0.42 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.00 | 700 | 2,100 | 71,623 | 70.9 K to 71.6 K (+0.99 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.99 | 2,600 | 7,774 | 70,923 | 68.3 K to 70.9 K (+3.81 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.99 | 1,800 | 5,382 | 68,323 | 66.5 K to 68.3 K (+2.71 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.99 | 750 | 2,242 | 66,523 | 65.8 K to 66.5 K (+1.14 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.98 | 400 | 1,192 | 65,773 | 65.4 K to 65.8 K (+0.61 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.98 | 300 | 894 | 65,373 | 65.1 K to 65.4 K (+0.46 %) |
Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.97 | 500 | 1,485 | 65,073 | 64.6 K to 65.1 K (+0.77 %) |